Pituitary pars intermedia dysfunction (Cushing’s syndrome) associated with pituitary adenoma in a mare
Authors:
Open Access
- 31 December 2024
- journal article
- Published by Editora da Universidade Federal Rural do Semi-Arido - EdUFERSA in Acta Veterinaria Brasilica
- Vol. 18 (4) , 313-318
Abstract
Pituitary pars intermedia dysfunction (PPID), also known as Cushing’s syndrome (CS) or hyperadrenocorticism, is a condition characterized by loss of dopaminergic inhibition of the pituitary pars intermedia. A Crioulo mare was presented with progressive weight loss, incoordination when walking, polydipsia, and a coat with a hirsute appearance. Loss of tail tone and muscle mass in the lumbar and gluteal regions, as well as long hair with a hirsute, opaque, and brittle appearance, were observed on inspection. In addition, the mare had small abscesses in the thoracolumbar region, and there were no other abnormalities on physical examination. The low-dose dexamethasone suppression test (DST) was performed to confirm the suspicion of CS, demonstrating a level of 4.6 µg/dL higher than baseline after 19h, confirming the diagnosis of PPID. The treatment consisted of cyproheptadine, and the animal showed improvement, being discharged from the hospital after 10 days. Continuation of the treatment was recommended on the farm. According to the veterinarian on the farm, the animal had been showing improvement, but it developed respiratory complications 10 days after discharge and died three days later. The main findings of the necropsy included severe diffuse granulomatous pneumonia, in addition to pituitary pars intermedia adenoma, which confirmed the clinical suspicion of PPID.Keywords
This publication has 14 references indexed in Scilit:
- Diagnosis of equine pituitary pars intermedia dysfunctionThe Veterinary Journal, 2023
- Evaluation of the sensitivity and specificity of basal plasma adrenocorticotrophic hormone concentration for diagnosing pituitary pars intermedia dysfunction in horses: A systematic reviewThe Veterinary Journal, 2021
- Clinical implications of using adrenocorticotropic hormone diagnostic cutoffs or reference intervals to diagnose pituitary pars intermedia dysfunction in mature horsesJournal of Veterinary Internal Medicine, 2020
- Efficacy of pergolide for the management of equine pituitary pars intermedia dysfunction: A systematic reviewThe Veterinary Journal, 2020
- Prevalence, risk factors and clinical signs predictive for equine pituitary pars intermedia dysfunction in aged horsesEquine Veterinary Journal, 2012
- A cross‐sectional study of geriatric horses in the United Kingdom. Part 1: Demographics and management practicesEquine Veterinary Journal, 2010
- Extrapituitary and Pituitary Pathological Findings in Horses with Pituitary Pars Intermedia Dysfunction: A Retrospective StudyJournal of Equine Veterinary Science, 2009
- Correlation of Pituitary Histomorphometry with Adrenocorticotrophic Hormone Response to Domperidone Administration in the Diagnosis of Equine Pituitary Pars Intermedia DysfunctionVeterinary Pathology, 2008
- Treatment with Pergolide or Cyproheptadine of Pituitary Pars Intermedia Dysfunction (Equine Cushing's Disease)Journal of Veterinary Internal Medicine, 2002
- Equine Cushing's Disease: Plasma Immunoreactive Proopiolipomelanocortin Peptide and Cortisol Levels Basally and in Response to Diagnostic Tests*Endocrinology, 1982